Skip to content
Cost Curve NewsCost Curve News
  • Home
  • About
  • News
  • Subscribe
06Oct2025
  • Home
  • About
  • News
  • Subscribe
06Oct2025
Cost Curve NewsCost Curve News
Cost Curve News

Appeals Court Rejects AstraZeneca’s IRA Suit, Including the Definition of ‘Drug’ Element

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv  
5 months ago
Keep Reading
Cost Curve News

The Administration Seems to Be Moving the MFN Push from Medicaid to Medicare. Buckle Up

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv  
5 months ago
Keep Reading
Cost Curve News

Pushing International Prices Into Medicaid Comes with a $1,000,000,000,000 Price Tag

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv  
5 months ago
Keep Reading
Cost Curve News

All Eyes Are on MFN … But Action and Specifics Remain Elusive

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv  
5 months ago
Keep Reading
Cost Curve News

A ‘Most-Favored Nation’ Approach in Medicaid Would Have Mammoth Unintended Consequences

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv  
5 months ago
Keep Reading
Cost Curve News

APEX | ‘Most-Favored Nation’ Is Floated by the White House … to a Frosty Reception from Congress

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv  
5 months ago
Keep Reading
Cost Curve News

APEX | Obesity Grabs the Headlines: Looking at a Novo Formulary Win and a New Paper on Budget Impact

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv  
5 months ago
Keep Reading
Cost Curve News

Earnings Calls Are Chockablock With Policy Talk This Month: MFN, PBMs, 340B, and More

BENDING YOUR EAR/ Cost Curve Apex Launches Tomorrow Cost Curve Apex -- the premium version of this newsletter -- launches tomorrow with the goal of ensuring I’m providing the best
5 months ago
Keep Reading
Cost Curve News

Novo and Telehealth Companies Team Up in the Next Turn of the Pharm-to-Table Story

If you want to search Cost Curve back issues or link to anything you read here, the web links and archive are online at costcurve.beehiiv.com. You can subscribe there, too.
5 months ago
Keep Reading
Cost Curve News

Thoughts on an Arnold Ventures-Backed Poll on ‘Negotiations’ That Fails to Account for Access/Innovation Tradeoffs

If you want to search Cost Curve back issues or link to anything you read here, the web links and archive are online at costcurve.beehiiv.com. You can subscribe there, too.
5 months ago
Keep Reading
101112

Latest Posts

Putting All of the Pharm-to-Table Resources in One Place

October 3, 2025

With the Pfizer/TrumpRx Announcement in the Rearview Mirror, Here Are Some Questions That Remain

October 2, 2025

The Four Elements of the Pfizer/Trump Deal to Keep an Eye On

October 1, 2025

Trump Makes a Deal with Pfizer on Medicaid and Announces a Direct-to-Patient Website

September 30, 2025

PhRMA Unveils a Three-Point Plan to Address Trump Concerns About Drug Prices and Manufacturing

September 29, 2025

Popular

Putting All of the Pharm-to-Table Resources in One Place

With the Pfizer/TrumpRx Announcement in the Rearview Mirror, Here Are Some Questions That Remain

The Four Elements of the Pfizer/Trump Deal to Keep an Eye On

Trump Makes a Deal with Pfizer on Medicaid and Announces a Direct-to-Patient Website

PhRMA Unveils a Three-Point Plan to Address Trump Concerns About Drug Prices and Manufacturing

Tariffs and MFN Dominate the Headlines, But Details Remain Scant

Most Viewed
  • CMS Patient-Focused Listening Session Transcripts (2,633)
  • Working Out the Strange Math and Weird Consequences of IRA Inflation Penalties (1,698)
  • New JAMA Research Shows How Much — and How Rapidly — Part D Plans Have Shifted Drug Costs to Consumers (1,611)
  • Bernie Sanders Wants to Talk to CEOs About US vs ROW Pricing. Bring It On, I Say. (1,491)
  • More IRA Lawsuits Coming, PhRMA Chief Predicts (1,473)

Your trusted source for daily updates on drug pricing and policy. Stay informed and ahead of the curve with Cost Curve News.

Latest News

Putting All of the Pharm-to-Table Resources in One Place

October 3, 2025

With the Pfizer/TrumpRx Announcement in the Rearview Mirror, Here Are Some Questions That Remain

October 2, 2025

Subcribe To Newsletter

Subscribe to our newsletter and stay informed about new posts and stay up-to-date on the latest news
Subscribe
© 2025 Cost Curve News | All Rights Reserved
Cost Curve NewsCost Curve News
  • Home
  • About
  • News
  • Subscribe